Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-23-001042
Filing Date
2023-01-24
Accepted
2023-01-24 16:00:53
Documents
1
Period of Report
2023-01-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-58266.html 4  
1 PRIMARY DOCUMENT marketforms-58266.xml 4 5769
  Complete submission text file 0001214659-23-001042.txt   7092
Mailing Address 3000 KENT AVENUE; SUITE A1-100 WEST LAFAYETTE IN 47906
Business Address
Meek David D. (Reporting) CIK: 0001555337 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 23548132

Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations